Vai al contenuto principale della pagina
Titolo: | Neglected tropical diseases - North America / / Jill E. Weatherhead, editor |
Pubblicazione: | Cham, Switzerland : , : Springer, , [2021] |
©2021 | |
Descrizione fisica: | 1 online resource (264 pages) |
Disciplina: | 616.96 |
Soggetto topico: | Parasitology |
Communicable diseases | |
Medical microbiology | |
Infection | |
Tropical Medicine - methods | |
Neglected Diseases | |
Medicina tropical | |
Soggetto geografico: | North America |
Amèrica del Nord | |
Soggetto genere / forma: | Llibres electrònics |
Persona (resp. second.): | WeatherheadJill E. |
Nota di contenuto: | Intro -- Preface -- Contents -- About the Editor -- Soil-Transmitted Helminthiasis -- 1 Introduction -- 1.1 Global Burden of Soil-Transmitted Helminths -- 2 Ascaris (Roundworm) -- 2.1 Epidemiology -- 2.2 Transmission -- 2.3 Clinical Manifestations -- 2.4 Diagnosis -- 2.5 Treatment -- 3 Hookworm -- 3.1 Epidemiology -- 3.2 Transmission -- 3.3 Clinical Manifestations -- 3.4 Diagnosis -- 3.5 Treatment -- 4 Trichuris (Whipworm) -- 4.1 Epidemiology -- 4.2 Transmission -- 4.3 Clinical Manifestation -- 4.4 Diagnosis -- 4.5 Treatment -- 5 Prevention -- References -- Toxocariasis -- 1 Introduction -- 2 Epidemiology -- 3 Transmission -- 4 Clinical Manifestations -- 5 Diagnosis -- 6 Treatment -- 7 Prevention -- 8 Conclusions -- References -- Strongyloidiasis -- 1 Introduction -- 2 Epidemiology -- 3 Transmission -- 4 Clinical Manifestations -- 5 Diagnosis -- 5.1 Screening Guidelines -- 5.2 Differential Diagnosis -- 6 Treatment -- 6.1 Available Pharmacologic Treatment -- 6.2 Treatment Approach -- 7 Prevention -- References -- Taeniasis and Cysticercosis -- 1 Introduction -- 2 Epidemiology -- 3 Taeniasis -- 3.1 Background -- 3.2 Clinical Manifestations -- 3.3 Diagnosis -- 3.4 Treatment -- 4 Cysticercosis -- 4.1 Background -- 4.2 Clinical Manifestations -- 4.3 Parenchymal NCC -- 4.3.1 Background -- 4.3.2 Diagnosis -- 4.3.3 Treatment -- 4.4 Ventricular NCC -- 4.4.1 Background -- 4.4.2 Diagnosis -- 4.4.3 Treatment -- 4.5 Subarachnoid (Racemose) NCC -- 4.5.1 Background -- 4.5.2 Diagnosis -- 4.5.3 Treatment -- 5 Prevention -- References -- Toxoplasmosis -- 1 Introduction -- 1.1 Parasite Genetics -- 1.2 Host Immune Response -- 2 Epidemiology -- 3 Transmission -- 4 Clinical Manifestations -- 4.1 In Immunocompetent Patients -- 4.1.1 Acute Infection -- 4.1.2 Chronic Infection -- 4.1.3 During Gestation and in the Offspring -- 4.2 In Immunocompromised (IC) Patients. |
4.3 Ocular Disease -- 5 Diagnosis -- 5.1 During Pregnancy -- 5.2 At Birth and Later in Life -- 5.3 Immunocompromised Patients (IC) -- 5.4 Ocular Disease -- 6 Treatment -- 7 Prevention -- 8 Conclusions -- References -- Chagas Disease -- 1 Introduction -- 1.1 History of Chagas Disease in the United States -- 2 Epidemiology -- 2.1 Immigrant Population -- 2.2 Autochthonous Populations -- 2.3 Blood Banks and Organ Donations -- 2.4 Congenital Populations -- 3 Transmission -- 4 Clinical Manifestations -- 5 Diagnosis -- 6 Treatment -- 7 Prevention -- 7.1 Physician Awareness -- 7.2 Patient Awareness -- 7.3 Public Health Surveillance -- 7.3.1 Barriers to Diagnosis and Treatment -- 7.4 Access Challenges for People with Chagas Disease -- 8 Conclusion -- References -- Leishmaniasis -- 1 Introduction -- 2 Epidemiology -- 3 Transmission -- 3.1 Host Factors -- 3.2 Parasite Factors -- 4 Clinical Manifestations -- 4.1 Cutaneous Leishmaniasis -- 4.2 Visceral Leishmaniasis -- 4.3 Mucosal Leishmaniasis -- 5 Diagnosis -- 5.1 Cutaneous Leishmaniasis -- 5.2 Visceral Leishmaniasis -- 6 Treatment -- 6.1 Amphotericin B -- 6.2 Antimony -- 6.3 Topical Paromomycin -- 6.4 Pentamidine -- 6.5 Miltefosine -- 7 Prevention -- References -- Trichomoniasis -- 1 Introduction -- 2 Epidemiology -- 3 Clinical Manifestations -- 3.1 T. vaginalis and HIV Transmission -- 3.2 T. vaginalis and Other STIs -- 3.3 T. vaginalis and Bacterial Vaginosis (BV) -- 3.4 T. vaginalis and Neoplasia -- 3.5 T. vaginalis and Perinatal Outcomes -- 4 Diagnosis -- 5 Treatment -- 5.1 Treatment in Pregnancy -- 5.2 Treatment in Patients with 5-Nitroimidazole Hypersensitivity -- 5.3 Management of Persistent Trichomoniasis -- 6 Prevention -- 7 Conclusion -- References -- Chikungunya, Dengue, Zika, and Other Emerging Mosquito-Borne Viruses -- 1 Introduction -- 2 Chikungunya Virus (CHIKV) -- 2.1 Epidemiology. | |
2.1.1 Virology and Ecology -- 3 Clinical Manifestations -- 3.1 Pathogenesis -- 3.2 Diagnosis -- 3.3 Treatment -- 3.4 Prevention -- 4 Dengue Virus (DENV) -- 4.1 Epidemiology -- 4.1.1 Virology and Ecology -- 4.2 Clinical Manifestations -- 4.2.1 Pathogenesis -- 4.3 Diagnosis -- 4.4 Treatment -- 4.5 Prevention -- 5 Zika Virus (ZIKV) -- 5.1 Epidemiology -- 5.1.1 Virology and Ecology -- 5.2 Clinical Manifestations -- 5.2.1 Pathogenesis -- 5.3 Diagnosis -- 5.4 Treatment -- 5.5 Prevention -- 6 Other Emerging Mosquito-Borne Viruses -- 6.1 Introduction -- 6.2 La Crosse Encephalitis Virus -- 6.3 Jamestown Canyon -- 6.4 St. Louis Encephalitis Virus -- 6.5 Eastern Equine Encephalitis Virus -- 6.6 Cache Valley Virus -- 6.7 Usutu Virus -- 6.8 Conclusions -- References -- West Nile Virus -- 1 Introduction -- 2 Epidemiology -- 2.1 Clinical and Financial Disease Burden -- 3 Transmission -- 4 Clinical Manifestations -- 4.1 Pathogenesis -- 4.2 Acute Clinical Presentation -- 4.3 Long-Term Complications -- 5 Diagnosis -- 6 Treatment -- 7 Vaccines -- 8 Hurdles to Elimination and Control -- 9 Conclusions -- References -- Hansen´s Disease -- 1 Introduction -- 2 Epidemiology -- 3 Transmission -- 3.1 Pathophysiology -- 4 Clinical Manifestations -- 4.1 Immune Reactions -- 5 Diagnosis -- 6 Treatment -- 7 Prevention -- 8 Conclusion -- References -- Murine Typhus -- 1 Introduction -- 1.1 History -- 1.2 Microbiology -- 1.3 Pathogenesis -- 2 Epidemiology -- 3 Transmission -- 4 Clinical Manifestations -- 4.1 Laboratory Features -- 5 Diagnosis -- 5.1 General Principles -- 5.2 Culture -- 5.3 Serology -- 5.4 Immunohistochemical Detection -- 5.5 Molecular Detection -- 6 Treatment -- 6.1 General Principles -- 6.2 Tetracyclines -- 6.3 Alternative Agents -- 7 Prevention -- References. | |
Titolo autorizzato: | Neglected Tropical Diseases - North America |
ISBN: | 3-030-63384-5 |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910484394803321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilitĂ qui |